Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Energy price falls spark drop in German and Spanish inflation
    • ‘Total distrust’: rise of the Russian informers
    • Russia detains Wall Street Journal reporter on suspicion of spying
    • Sheikh Mohammed bin Zayed names his son crown prince of Abu Dhabi
    • Donald Trump indicted on criminal charges in New York
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Banks in turmoil
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • How rising interest rates are exposing bank weaknesses
      • Revolut board frustrated by fintech company’s response to audit warning
      • London loses sole lead as world’s top financial centre
      • Walt Disney ousts Marvel chair Isaac Perlmutter after he clashed with CEO Bob Iger
      • Boutique adviser Centerview beats Wall Street banks in deal rankings
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • How rising interest rates are exposing bank weaknesses
      • Live news updates from March 30: Donald Trump indicted, Finland cleared to join Nato
      • Revolut board frustrated by fintech company’s response to audit warning
      • London loses sole lead as world’s top financial centre
      • European real estate stocks hammered by banking turmoil
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • Prepare for a multipolar currency world
      • Multiple red flags are not yet slowing the generative AI train
      • Fox News’ populist mask has slipped
      • ‘Succession’ triumph may mark a bookend for the ‘peak TV’ era
      • Lessons from a big bet on poverty statistics
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Matthew Desmond: ‘America does so much more to subsidise affluence than alleviate poverty’
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • I used AI to bet on horse-racing. Here’s what happened
      • It’s morally repugnant, but isolationism on Ukraine makes some sense
      • The Zara woman: an exclusive interview with Marta Ortega Pérez
      • The Noble Rot guide to Burgundy
      • Gwyneth Paltrow, ‘stealth wealth’ star of the courtroom catwalk
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Intellectual property

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Tuesday, 28 February, 2023
      Stephen Bush
      Roald Dahl and the giant problem with intellectual property

      The question of who should tweak works, and when, baffles fans and authors alike

    • Sunday, 26 February, 2023
      Pharmaceuticals sector
      Big Pharma fights patent disclosure demand from investors

      Industry rejects call for transparency over use of strategy that can delay competition from generic medicines

    • Friday, 24 February, 2023
      John Gapper
      The painfully high price of Humira is patently wrong

      Specialist drugs sold by Big Pharma are so expensive that many patients are being excluded

    • Friday, 17 February, 2023
      Undercover EconomistTim Harford
      Can gamers outplay the rapacious capitalists?

      Role-playing games like Dungeons & Dragons are having a moment in the spotlight – and offer valuable lessons to the rest of the economy

    • Wednesday, 15 February, 2023
      Jayasree Iyer
      Poor countries desperately need better access to generic medicines

      Manufacturers showed during the pandemic that they can deliver low-cost treatments at scale

    • Wednesday, 8 February, 2023
      Hermès wins landmark lawsuit over ‘MetaBirkin’ NFTs

      New York jury rejected artist’s claim that digital depictions of luxury bags was legally protected expression

    • Wednesday, 8 February, 2023
      Special Report
      Europe’s Leading Patent Law Firms

      Apply for the 2023 ranking, and read last year’s coverage

    • Wednesday, 8 February, 2023
      Special ReportEurope’s Leading Patent Law Firms
      Call for entries: Europe’s Leading Patent Law Firms 2023

      Clients and peers are invited to recommend firms and rate them for specialist expertise

    • Tuesday, 31 January, 2023
      AbbVie Inc
      Blockbuster AbbVie drug Humira to face competition in US for first time

      Amgen to launch ‘biosimilar’ version of medicine that has generated $200bn in sales since launch

    • Monday, 30 January, 2023
      The Big Read
      The growing tensions around spinouts at British universities

      Millions of pounds are being invested to turn scientific research into global companies. But some founders say they have to give up too much equity

    • Friday, 27 January, 2023
      Watches & Jewellery
      Finematter digital certificates smooth way for circular jewellery economy

      Platform aims to increase transparency on provenance of pieces from smaller makers, boosting resale potential

    • Saturday, 21 January, 2023
      News in-depthArtificial intelligence
      Art and artificial intelligence collide in landmark legal dispute

      Getty Images and others are challenging AI companies’ use of copyrighted images to train their image-generating algorithms

    • Wednesday, 18 January, 2023
      Artificial intelligence
      An AI just passed a university exam (but don’t panic: it was only economics)

      Skynet hits the books

    • Wednesday, 7 December, 2022
      Trade disputes
      EU challenges China at WTO over Lithuania trade embargo and tech patents

      Bloc asks global body to convene panels to rule on two trade disputes

    • Tuesday, 8 November, 2022
      Covid-19 vaccines
      Patent wars: Moderna’s battle for the spoils of Covid vaccines

      Ending of pharma group’s IP truce spells fight for future of mRNA technology

    • Saturday, 1 October, 2022
      Moderna
      Moderna refused China request to reveal vaccine technology

      Pharma company still ‘eager’ to collaborate with Beijing, despite collapse of initial talks

    • Wednesday, 31 August, 2022
      Arm Ltd
      Chip design group Arm sues Qualcomm for breach of contract

      Lawsuit centres on US company’s purchase of start-up Nuvia

    • Tuesday, 30 August, 2022
      Inside BusinessPrimrose Riordan
      China’s intellectual property landscape is maturing

      Foreign companies are finally winning the battle to trademark names — but is the cost worth it?

    • Friday, 26 August, 2022
      Covid-19 vaccines
      Moderna accuses BioNTech/Pfizer of copying mRNA technology

      US biotech claims rival Covid vaccine makers infringed patents underpinning jabs developed to combat the pandemic

    • Monday, 22 August, 2022
      Sony Corp
      Sony PlayStation faces UK class action lawsuit of up to £5bn

      Company is being sued over allegations it overcharged millions of customers

    • Sunday, 21 August, 2022
      Leo Lewis
      Parody takes a serious turn for big name brands

      A decision by the Japan Patent Office appears to credit the consumer with more discernment than trademark owners do

    • Saturday, 30 July, 2022
      FT Magazine
      When Hitler stole a cookbook

      It’s not just million-dollar paintings. The race is on to track down the everyday objects that are looted in war

    • Tuesday, 19 July, 2022
      Manolo Blahnik
      Manolo Blahnik wins 22-year legal fight over China trademark

      Ruling will enable luxury British shoemaker to sell in country directly for first time

    • Tuesday, 5 July, 2022
      CureVac GmbH
      CureVac sues BioNTech over mRNA patents

      Pharma group seeks compensation from Covid vaccine maker for alleged IP infringements

    • Sunday, 3 July, 2022
      UK business & economy
      UK moves closer to US-style class actions 

      Landmark case signals shift for consumers towards mass lawsuits over antitrust breaches 

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Banks in turmoil
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In